ProQR Raises $90m To Advance Eye Disease Pipeline
Lead Candidates For LCA10 And Usher Syndrome
The Dutch biotech has firmed up its finances as its promising pipeline of RNA therapies for rare genetic eye disease starts to move through the clinic.
The Dutch biotech has firmed up its finances as its promising pipeline of RNA therapies for rare genetic eye disease starts to move through the clinic.